Cohen Cheryl Insider Trading Activity

Average Profitability
12.02%
Insider Buys Quantity
1
Insider Buys Sum
$50,179.50
Insider Sells Quantity
6
Insider Sells Sum
$1.01M

Insider Activity of Cohen Cheryl

According to the SEC Form 4 filings, Cohen Cheryl, being in a position of

  1. director at ImmunityBio, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 212266 shares for $2.1M,
    over all time since 2020-08-11, has bought 0 shares, and sold 312574 shares for $3.11M.

Biography of Cohen Cheryl

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,098,0292100

Comparison of Insiders on Amount of Buys and Sells

2026-10-02SaleImmunityBio, Inc.
IBRX
director
81,056
0.0079%
$10.50$851,088-14.54%
2026-07-02SaleImmunityBio, Inc.
IBRX
director
131,210
0.0126%
$9.50$1.25M-13.51%
2021-08-23SaleImmunityBio, Inc.
IBRX
director
14,801
0.0035%
$10.12$149,795-45.86%
2021-08-20SaleImmunityBio, Inc.
IBRX
director
9,976
0.0025%
$10.00$99,808-41%
2021-08-18SaleImmunityBio, Inc.
IBRX
director
2,133
0.0006%
$10.03$21,389-36.74%
2021-08-17SaleImmunityBio, Inc.
IBRX
director
43,398
0.0112%
$10.12$439,361-41.04%
2020-08-11SaleImmunityBio, Inc.
IBRX
director
30,000
0.0083%
$9.96$298,785+46.4%
2018-09-12SaleImmunic, Inc.
IMUX
director
7,000
0.0202%
$0.55$3,850-34.89%
2015-10-26PurchaseImmunic, Inc.
IMUX
director
7,000
0.0243%
$7.17$50,180+12.02%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.